[PSA] MHRA supply notice out, expect pharmacy stock weirdness
MHRA supply notice out, expect pharmacy stock weirdness — with the reasoning, because a rule without a reason gets ignored.
Scotland, Wales and Northern Ireland have their own arrangements. An answer that begins with "in England" should say so, and most of the confusion here comes from answers that do not.
Supply notices from the regulator describe expected availability at a national level. They do not predict what any individual pharmacy has on the shelf next week.
Discharge from a specialist service at goal is a normal end point of that pathway. Whether prescribing continues in primary care afterwards is a local decision and is worth asking about at the start rather than at the end.
Tell me where this is wrong. That is the useful part of posting it.
best — the order this archive was captured in
Yes — four nations, four pathways, and threads that ignore that give people the wrong answer confidently.
Left up. It names a nation and an ICB, which is all we ask of a pathway post.
I would not read a supply notice as a shortage in your pharmacy tomorrow. They are not the same thing.
[removed by moderator]
private prescription pricing moves monthly and the pharmacy is most of the spread
Concentrations can differ between products and between pharmacies. Switching mid-titration means redoing the arithmetic rather than carrying the old unit count across.
Small fix — that is the Scottish pathway. The post is asking about England and the answer is different.
Correcting myself: the referral was 17 months ago, not the figure I gave. I keep rounding it down.